Suppr超能文献

接受嗜铬细胞瘤或副神经节瘤切除术的间变酪氨酸酶患者的围手术期血液动力学和结局。

Perioperative hemodynamics and outcomes of patients on metyrosine undergoing resection of pheochromocytoma or paraganglioma.

机构信息

Department of Surgery, Mayo Clinic, Rochester, MN, USA.

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.

出版信息

Int J Surg. 2017 Oct;46:1-6. doi: 10.1016/j.ijsu.2017.08.026. Epub 2017 Aug 10.

Abstract

INTRODUCTION

To describe outcomes of patients with metyrosine (MET) pretreatment for abdominal surgical resection of pheochromocytoma or paraganglioma (PCC/PGL) compared with patients who had phenoxybenzamine (PBZ) pretreatment.

METHODS

Retrospective review of perioperative outcomes for PCC/PGL patients treated with MET and propensity-matched comparison of MET and PBZ (MET + PBZ) with PBZ alone.

RESULTS

MET preparation was given in 63 cases (26 laparoscopic and 37 open, of which 55 also received PBZ). All patients had wide perioperative hemodynamic oscillations. Patients with open procedures required more intravenous fluids and blood transfusions; 35% required postoperative vasopressor infusions for hypotension and 38% developed acute kidney injury. One laparoscopic procedure required postoperative vasopressor infusion, and 12% of patients developed acute kidney injury. Forty-five MET + PBZ patients were propensity-matched with PBZ-only patients. Intraoperatively, MET + PBZ patients had lower minimum systolic and diastolic blood pressures than PBZ-only patients (median systolic, 74 vs 80 mm Hg, P = 0.01; median diastolic, 42 vs 46 mm Hg, P = 0.005) and larger intraoperative blood pressure oscillations (median systolic range, 112 vs 93 mm Hg, P = 0.06; median diastolic range, 58 vs 51 mm Hg, P = 0.02). Postoperative vasopressor infusion use was similar between MET + PBZ and PBZ only (16% vs 11%, P = 0.76). Major outcomes were not different between regimens.

CONCLUSION

Large hemodynamic oscillations were present in our PCC/PGL patients treated with MET + PBZ. These patients had a wider range of intraoperative blood pressure variations than PBZ-only patients. No differences in postoperative comorbid outcomes were found between MET + PBZ and PBZ-only groups.

摘要

简介

描述使用美替拉宗(MET)预处理的患者与使用苯氧苄胺(PBZ)预处理的患者在接受腹部外科切除嗜铬细胞瘤或副神经节瘤(PCC/PGL)方面的术后结果。

方法

回顾性分析接受 MET 治疗的 PCC/PGL 患者的围手术期结果,并对 MET 和 PBZ(MET+PBZ)与单独使用 PBZ 进行倾向评分匹配比较。

结果

63 例患者接受了 MET 预处理(26 例腹腔镜手术,37 例开放手术,其中 55 例还接受了 PBZ 治疗)。所有患者均有广泛的围手术期血流动力学波动。开放手术患者需要更多的静脉输液和输血;35%的患者因低血压需要术后血管加压素输注,38%的患者发生急性肾损伤。1 例腹腔镜手术需要术后血管加压素输注,12%的患者发生急性肾损伤。45 例 MET+PBZ 患者与单独使用 PBZ 的患者进行倾向评分匹配。术中,MET+PBZ 患者的收缩压和舒张压均低于单独使用 PBZ 的患者(收缩压中位数为 74 对 80mmHg,P=0.01;舒张压中位数为 42 对 46mmHg,P=0.005),且术中血压波动更大(收缩压范围中位数为 112 对 93mmHg,P=0.06;舒张压范围中位数为 58 对 51mmHg,P=0.02)。MET+PBZ 和单独使用 PBZ 的患者术后使用血管加压素输注的情况相似(16%对 11%,P=0.76)。两种方案的主要结局没有差异。

结论

接受 MET+PBZ 治疗的 PCC/PGL 患者存在较大的血流动力学波动。这些患者的术中血压变化范围大于单独使用 PBZ 的患者。在术后合并症结局方面,MET+PBZ 组与单独使用 PBZ 组无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验